JaxBio
About
JaxBio develops a simple, fast, and highly sensitive blood test for the early diagnosis of cancer. Their technology utilizes artificial intelligence to probe thousands of cancer-specific biomarkers, enabling the identification of different cancer types and subtypes at various stages. This aims to improve cancer detection, monitoring, and treatment response prediction.
Technology stack
detected 2026-06-25Email
Google Workspace
Hosting
self_managed
Stack
jQuery
WordPress
SEO
Yoast SEO
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does JaxBio do?
JaxBio develops a simple, fast, and highly sensitive blood test for the early diagnosis of cancer. Their technology utilizes artificial intelligence to probe thousands of cancer-specific biomarkers, enabling the identification of different cancer types and subtypes at various stages. This aims to improve cancer detection, monitoring, and treatment response prediction. (formerly JaxBio Technologies.)
How much funding has JaxBio raised?
JaxBio has raised a total of $22M in funding. The most recent round on record is Grant.
Where is JaxBio headquartered?
JaxBio is headquartered in San Francisco, United States.
When was JaxBio founded?
JaxBio was founded in 2021.
What industry does JaxBio operate in?
JaxBio operates in Life Sciences, Biotech, Blood, Biomarkers, Oncology, Cancer.
How many employees does JaxBio have?
JaxBio has approximately 13 people on record.